Does the HPV Vaccine Hurt? What to Expect

The HPV vaccine does hurt for most people, but the pain is typically mild and short-lived. In surveys of parents whose daughters received the vaccine, about two-thirds reported their child experienced some pain or discomfort, yet only around one in ten described the pain at injection as even moderate, and severe pain was reported by roughly 2% or fewer. What you feel during and after the shot, how long it lasts, and what you can do about it are all predictable enough that the experience rarely derails anyone’s vaccination plans.

What the Shot Feels Like in the Moment

The HPV vaccine is given as an intramuscular injection in the upper arm. The needle enters the deltoid muscle, and you feel a quick pinch or sting that lasts a few seconds. Most of the immediate sensation comes from the needle itself, not the vaccine liquid, though some people notice a brief burning or pressure as the fluid enters the muscle.

In a study of 229 parents reporting on their daughters’ experiences, about 58% said their child felt pain at the time of the injection. But the intensity was rarely high: only about 10% described the pain as moderate and just 2% called it severe. The remainder felt it was mild, the kind of discomfort that fades within minutes of sitting back down in the waiting room.¹

The Hours and Days Afterward

After the initial sting subsides, a different kind of soreness often sets in. Your arm may feel tender, stiff, or achy around the injection site, sometimes accompanied by redness or swelling. In a Japanese clinical trial of the quadrivalent HPV vaccine, about 86% of vaccine recipients reported some kind of injection-site reaction, compared with about 72% of those who received a placebo injection, meaning some of the soreness comes simply from having a needle stuck in your muscle. Most of these local reactions appeared within three days and resolved within five days. Only about 2% of vaccine recipients reported a severe local reaction.²

Among parents surveyed in the U.S., about 45% reported their daughters experienced pain in the hours and days after the shot, with that lingering soreness lasting a median of about two days. For most people, the arm tenderness peaks sometime during the first 24 to 48 hours, then gradually fades. A small number reported discomfort lasting a week or more, but this was uncommon.¹

Systemic Side Effects Beyond the Arm

The HPV vaccine can also cause whole-body symptoms that have nothing to do with the injection site. A systematic review of HPV vaccine trials found that headache and fatigue were the most common systemic complaints, showing up in roughly half to 60% of all participants. That sounds high until you consider that these same symptoms appeared at similar rates in placebo groups in many trials, which means some of what people experience is unrelated to the vaccine itself. When these symptoms do occur, they are mostly mild or moderate.³

Low-grade fever, nausea, muscle aches, and dizziness round out the list of possible systemic reactions, but they affect a smaller proportion of people and tend to clear up within a day or two. Over-the-counter pain relievers like ibuprofen or acetaminophen are generally fine to take if the headache or body aches bother you, though many people ride it out without any medication at all.

Does Pain Change from Dose to Dose?

The HPV vaccine is given as either two or three doses depending on your age. A reasonable worry is that each shot will hurt worse than the last. The evidence on this is a little mixed. An Italian post-licensure study of the bivalent HPV vaccine found that pain at the injection site was actually reported more frequently after the first dose than after subsequent ones. Other local and systemic symptoms, like swelling and fatigue, were more common after the third dose.⁴

In practical terms, the first shot tends to be the most painful in the moment, partly because your body hasn’t encountered the vaccine before and partly because of the anxiety of not knowing what to expect. By the second and third doses, most people find the injection itself less surprising, even if the arm soreness or systemic symptoms are comparable or slightly more noticeable. Either way, the differences between doses are modest enough that they rarely matter in a person’s decision to come back for the next one.

Fainting and Dizziness

One side effect that gets outsized attention is syncope, the medical term for fainting. This risk applies to adolescents receiving any vaccine, not just the HPV shot, and it seems driven more by the experience of being injected than by anything specific in the vaccine formula. In a large study of adolescent vaccination events, the rate of confirmed vaccine-associated syncope was about 3 per 10,000 vaccinations, which increased when multiple vaccines were given on the same visit. For context, the same study found that syncope after a routine blood draw was far more common, at roughly 16 per 10,000 events.⁵

An Australian review of HPV-specific reports found that syncope and syncopal seizures (brief involuntary movements that happen during a faint) occurred at rates consistent with what was seen in other countries. Injuries from fainting were uncommon but real, including one case of a vertebral fracture from a fall. Clinics that identified high-risk patients and administered later doses while the patient was lying down reported no recurrences of fainting.⁶

The standard recommendation is to sit or lie down for about 15 minutes after the injection. If you know you are prone to feeling lightheaded around needles, mention this to the person giving the shot. They can have you lie down beforehand and keep you there longer afterward. The faint itself is not dangerous; the concern is hitting something on the way down.

Why Anxiety Makes the Pain Worse

How much the shot hurts is not purely physical. Fear and anxiety amplify pain perception, and the HPV vaccine is given at an age when needle anxiety can be especially strong. A qualitative study of 11- to 12-year-old girls found that their main expectations before the HPV vaccine fell into three categories: it was going to hurt, they were going to be scared, and ultimately it would turn out fine. These expectations were shaped by previous experiences with needles and by what they’d heard from friends and family.⁷

There is also evidence that early negative experiences with needles cast a long shadow. Researchers found that children who received more same-day injections during their preschool vaccinations reported higher needle fear years later as preadolescents. Those in the highest fear group were less likely to begin the HPV vaccine series compared with those with lower fear, though the difference was not statistically significant in the study’s sample.⁸

The upshot: if you or your child tend to dread needles, the anticipation can genuinely make the injection feel worse than it would otherwise. Acknowledging the fear honestly, rather than dismissing it, and using simple coping strategies like deep breathing or looking away during the injection tend to help more than a generic “it won’t be that bad.”

Practical Ways to Reduce Pain

You don’t have to just white-knuckle it. Several strategies can meaningfully dial down the sting of the injection and the soreness that follows.

One approach with some evidence behind it is light exercise around the time of vaccination. In a randomized trial of adolescents receiving the HPV vaccine, female participants assigned to exercise shortly before or after the shot reported significantly less pain than those who did nothing. Females in the exercise group also reported less anxiety and fear than females in the control group.⁹ A follow-up analysis from the same research group found that exercise also appeared to reduce the number of days participants felt tender and sore afterward, and lowered the duration of swelling and reduced appetite.¹

Injection technique also matters. A study comparing standard intramuscular injection to two alternative methods found that using a device called a ShotBlocker, a small plastic tool pressed against the skin near the injection site to confuse local nerve signals, significantly reduced reported pain compared to standard practice. The Helfer Skin Tap technique, which involves tapping the skin rhythmically before injection, also outperformed the standard approach, though it was not as effective as the ShotBlocker.¹⁰

Other methods children and teens have identified as helpful include distraction (watching a video, listening to music, squeezing a stress ball), topical anesthetic creams applied before the visit, and having a calm and trusted adult present. These are simple enough that there’s no reason not to try them if pain is a concern.

Gardasil 9 Versus Older Formulations

The HPV vaccine currently used in most countries is Gardasil 9, which protects against nine HPV types. It replaced the earlier quadrivalent version (Gardasil 4), which covered four types, and the bivalent Cervarix, which covered two. Because Gardasil 9 contains more antigens and a higher concentration of the aluminum-based adjuvant that helps stimulate the immune response, researchers have asked whether it stings more than its predecessors.

In a randomized trial directly comparing the two in girls aged 9 to 15, Gardasil 9 and the older Gardasil showed comparable safety profiles overall, though the newer vaccine produced more injection-site swelling.¹¹ A review of post-market adverse event reports noted that the slight increase in local reactogenicity and systemic complaints seen with Gardasil 9 in trials may be linked to its higher antigenic load and adjuvant concentration.¹² In practical terms, the difference between the two is small: a bit more swelling, maybe slightly more arm soreness. Neither version produced meaningfully different rates of serious side effects.

Long-Term Safety and Serious Reactions

For many people, the question behind “does it hurt?” is really “is it safe?” Short-term pain is tolerable; the worry is that something lasting or harmful could happen. The reassuring answer from large-scale surveillance is that the vast majority of reported adverse events after the HPV vaccine are non-serious and resolve on their own.

An analysis of 18 years of U.S. Vaccine Adverse Event Reporting System (VAERS) data found no safety signals for neurological or autoimmune conditions like Guillain-Barré syndrome or demyelinating diseases, which had been flagged as theoretical concerns in earlier discussions.¹³ A separate decade-long VAERS analysis of Gardasil 9 specifically confirmed an overall favorable safety profile, with most reports describing non-serious, self-limiting events. The analysis did flag a handful of very rare potential signals, including anaphylaxis and certain autonomic or autoimmune conditions, but emphasized that these occurred at extreme rarity relative to the millions of doses administered and that the passive reporting system makes it impossible to confirm the vaccine actually caused them.¹⁴

An earlier analysis of VAERS data from 2007 to 2017 reached essentially the same conclusion: the side effects most commonly reported were non-serious and already listed on the vaccine’s label. Nothing new or alarming emerged from a decade of real-world monitoring.¹⁵

Does the Pain Scare People Away from Finishing the Series?

A lingering concern among public health researchers is whether the discomfort from the first HPV vaccine dose discourages people from coming back for the second or third. If the shot hurts enough to derail the series, that is a real problem, since incomplete vaccination offers less protection.

The data suggest this is mostly a non-issue. In the same parental survey that documented how common post-vaccine pain was, pain did not predict whether daughters completed the series on time. Parents whose daughters finished on schedule reported injection-time pain at nearly the same rate (62%) as parents whose daughters fell behind (68%), and the difference was not statistically significant.¹

When people do fall behind on their HPV vaccine series, the reasons tend to be logistical, such as scheduling difficulties and insurance gaps, rather than pain-driven. That said, needle fear in the broader sense, not just the memory of the last shot’s soreness, does influence whether some adolescents begin the series at all. Addressing fear before the first dose matters more than managing pain after it.

The Role of Misinformation in Shaping Expectations

What you expect going into the HPV vaccine often depends on what you’ve read or heard, and some of that information is flatly wrong. Dramatic stories about severe vaccine reactions circulate widely on social media, often exaggerating rare events or attributing unrelated health problems to the vaccine. A study examining HPV vaccine-related social media posts found that posts containing misinformation produced lower trust in the vaccine and higher perceived risk compared to accurate posts. Posts without misinformation were associated with about six times higher motivation to get vaccinated than those containing false claims.¹⁶

This matters because inflated expectations of pain or danger can become self-fulfilling. A teenager who has absorbed alarming stories about the vaccine is likely to approach the injection with more anxiety, which in turn makes the pain feel worse. The most useful preparation involves knowing the actual odds: most people feel a mild sting and some arm soreness for a couple of days, and serious reactions are exceedingly rare.

Who Tends to Report More Pain

Pain perception varies across individuals, but a few patterns show up consistently in the research. Females tend to report more pain from the HPV vaccine than males. In the exercise trial mentioned earlier, females in the control group reported significantly higher pain and anxiety than males in the same group.⁹ Whether this reflects a genuine biological difference in pain sensitivity, differences in how boys and girls are socialized to report pain, or some combination of both is still debated. In the exercise group, the gap between males and females disappeared, which hints that the difference is at least partly modifiable.

Age plays a role, too. Younger adolescents, who may have less experience with injections and more active fear responses, sometimes report higher pain scores than older teens and adults. Body composition can also factor in: the HPV vaccine is meant to reach muscle tissue, and in people with less deltoid muscle mass, the needle may cause a slightly different sensation. None of these factors change the overall picture, which is that most people handle the shot without difficulty, but they can explain why your experience might differ from someone else’s.

What Recovery Actually Looks Like

For the average person, the timeline after an HPV vaccine dose looks something like this. Within the first few minutes, the pinch at the injection site fades. Over the next several hours, a dull soreness develops in the arm, sometimes accompanied by slight redness or a small area of swelling. This peaks around 24 to 48 hours and then begins to resolve. Most local reactions clear up within five days.² If headache or fatigue shows up, it tends to arrive on the first day and resolve by the second. You can use the arm normally, though reaching overhead or sleeping on that side may be uncomfortable the first night. Applying a cool cloth to the area, moving the arm gently, and staying hydrated are all simple ways to ease the soreness without medication.

If your arm is still painful or swollen after a week, or if you develop a high fever, hives, or difficulty breathing shortly after the injection, contact a healthcare provider. These would be unusual and worth evaluating, even though the overwhelming likelihood is that everything resolves uneventfully on its own.

1
PubMed Central. How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen
2
Papillomavirus Research. Post-hoc analysis of injection-site reactions following vaccination with quadrivalent human papillomavirus vaccine in Japanese female clinical trial participants
3
The Brazilian Journal of Infectious Diseases. Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review
4
PubMed. Safety and tolerability of bivalent HPV vaccine: an Italian post-licensure study
5
PubMed Central. Incidence of Adolescent Syncope and Related Injuries Following Vaccination and Routine Venipuncture
6
PubMed. Syncope and seizures following human papillomavirus vaccination: a retrospective case series
7
PubMed. Expectation prior to human papilloma virus vaccination: 11 to 12-Year-old girls’ written narratives
8
PubMed Central. The number of injected same-day preschool vaccines relates to preadolescent needle fear and HPV uptake
9
Vaccine. The effect of exercise on vaccine-related pain, anxiety and fear during HPV vaccinations in adolescents
10
Clinical and Experimental Health Sciences. The Effect of Helfer Skin Tap Technique and ShotBlocker Application on Pain in Deltoid Muscle Injection
11
The Pediatric Infectious Disease Journal. A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls
12
PubMed Central. Adverse events following 9-valent human papillomavirus vaccine (GARDASIL® 9) reported to the Vaccine Adverse Event Reporting System (VAERS), 2015–2024
13
PubMed Central. Real-world safety of HPV vaccines over 18 y: A comprehensive analysis of U.S. VAERS reports
14
Frontiers in Public Health. Post-licensure safety surveillance of 9-valent human papillomavirus vaccine using the vaccine adverse event reporting system, 2014–2024
15
PubMed Central. Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
16
PubMed Central. Misinformation and other elements in HPV vaccine tweets: an experimental comparison